Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues.
The Santa Clara, California-based medical devices company said its first-quarter profit, on an adjusted basis, rose to $1.37 per share from $1.21 per share in the year-ago period.
Unadjusted net income moved up to $352 million or $1.19 per share from $283 million or $0.93 per share in the corresponding quarter of 2022. At $1.76 billion, revenues were up 5% from last year.
Check this space to read management/analysts’ comments on quarterly reports
“The Agilent team delivered an excellent start to 2023 with broad-based growth across our end markets and geographic regions. These positive results reflect the resiliency and durability of our diversified business and put us in a solid position for the year ahead,” said Agilent’s CEO Mike McMullen.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was